[The Petri Dish] Is Biotechnology the new mantra for wealth creation?

By KASS International Biotechnology is no longer just the domain of white lab coats and research institutions. It has quietly, and then suddenly, become one of the most powerful engines of wealth creation in the 21st century. From gene-editing tools to personalised medicine, the biotechnology sector is attracting billions in investment, spawning unicorns, and fundamentally […]

Missed Your Deadline in Singapore?

This was certainly a “killer” case in Singapore (couldn’t resist the pun!). The unfortunate party here is KPR Singapore Pte Ltd, the Applicants of the mark “KPR & Device”. The filing of an extension of time to file a Counter Statement in an opposition proceeding in Singaporeafter the expiry of the 4-month deadline given by the […]

Unilab Trumps Pfizer in the Philippines

By KASS International In a recent case at the Makati Regional Trial Court of the Philippines, the world’s largest pharmaceutical company, Pfizer Inc., lost a court action to obtain an injunction preventing a Filipino generic drug manufacturing company, United Laboratories Inc. (Unilab) from producing and selling its version of Atorvastatin Calcium which is the subject […]

[Trademart] Using IP Rights to Protect Green Technology

By KASS International The green economy is no longer a niche concern for environmental advocates. It is a mainstream commercial reality, and one that is reshaping investment priorities, regulatory frameworks, and competitive dynamics across virtually every industry. As businesses race to develop cleaner processes, renewable energy solutions, and sustainable products, the intellectual property rights that […]